Human coagulation factor IX: direct depletion and recovery from plasma, using immobilised monoclonal antibody.

H. Bessos,C. Prowse,K. James

1988-07-01

Abstract:

What problem does this paper attempt to address?

Evolutionary approach to the analysis of structure and function of gangliosides

N. Avrova

DOI: https://doi.org/10.1007/BF00988866

IF: 4.4

1985-11-01

Neurochemical Research

Abstract:
Characterization of Bacterial Biofilms for Wastewater Treatment

S. Andersson

Abstract:Research performed at the Division of Environmental Microbiology has over the last years resulted in the isolation of possible bacterial key-organisms with efficient nutrient removal properties (Co ...
Investigating Causal Relations Between Circulating Metabolites and Alzheimer's Disease: A Mendelian Randomization Study

Shu-Yi Huang,Yu-Xiang Yang,Ya-Ru Zhang,Kevin Kuo,Hong-Qi Li,Xue-Ning Shen,Shi-Dong Chen,Ke-Liang Chen,Qiang Dong,Lan Tan,Jin-Tai Yu

DOI: https://doi.org/10.3233/jad-220050

2022-01-01

Journal of Alzheimer s Disease

Abstract:BACKGROUND:Metabolomics is a promising approach that can be used to understand pathophysiological pathways of Alzheimer's disease (AD). However, the causal relationships between metabolism and AD are poorly understood.OBJECTIVE:We aimed to investigate the causal association between circulating metabolites and risk of AD through two-sample Mendelian randomization (MR) approach.METHODS:Genetic associations with 123 circulating metabolic traits were utilized as exposures. Summary statistics data from International Genomics of Alzheimer's Project was used in primary analysis, including 21,982 AD cases and 41,944 controls. Validation was performed using family history of AD data from UK Biobank (27,696 cases of maternal AD, 14,338 cases of paternal AD, and 272,244 controls). We utilized inverse-variance weighted method as primary method.RESULTS:We found significantly increased risks of developing AD per standard deviation increase in the levels of circulating ApoB (odd ratio[OR] = 3.18; 95% confidence interval[CI]: 1.52-6.66, p = 0.0022), glycoprotein acetyls (OR = 1.21; 95% CI: 1.05-1.39, p = 0.0093), total cholesterol (OR = 2.73; 95% CI: 1.41-5.30, p = 0.0030), and low-density lipoprotein (LDL) cholesterol (OR = 2.34; 95% CI: 1.53-3.57, p = 0.0001). Whereas glutamine (OR = 0.81; 95% CI: 0.71-0.92, p = 0.0011) were significantly associated with lower risk of AD. We also detected causal effects of several different composition of LDL fractions on increased AD risk, which has been verified in validation. However, we found no association between circulating high-density lipoprotein cholesterol and AD.CONCLUSION:Our findings suggest causal effects of circulating glycoprotein acetyls, ApoB, LDL cholesterol, and serum total cholesterol on higher risk of AD, whereas glutamine showed the protective effect.
The Potential Effect of Aberrant Testosterone Levels on Common Diseases: A Mendelian Randomization Study

Ali Alamdar Shah Syed,Lin He,Yongyong Shi

DOI: https://doi.org/10.3390/genes11070721

IF: 4.141

2020-01-01

Genes

Abstract:Testosterone has historically been linked to sexual dysfunction; however, it has recently been shown to affect other physical and mental attributes. We attempted to determine whether changes in serum testosterone could play a role in chronic or degenerative diseases. We used two separate genetic instruments comprising of variants fromJMJD1CandSHBGregions and conducted a two-sample Mendelian randomization for type II diabetes (T2D), gout, rheumatoid arthritis (RA), schizophrenia, bipolar disorder, Alzheimer's disease and depression. For theJMJD1Clocus, one unit increase in log transformed testosterone was significantly associated with RA (OR = 1.69,p= 0.02), gout (OR = 0.469,p= 0.001) and T2D (OR = 0.769,p= 0.048). Similarly, one unit increase in log transformed testosterone using variants from theSHBGlocus was associated with depression (OR = 1.02,p= 0.001), RA (OR = 1.32,p< 0.001) and T2D (OR = 0.88,p= 0.003). Our results show that low levels of serum testosterone levels may cause gout and T2D, while higher than normal levels of testosterone may result in RA and depression. Our findings suggest that fluctuations in testosterone levels may have severe consequences that warrant further investigation.
Investigating Causal Relations Between Circulating Metabolites and Alzheimer’s Diseases: A Mendelian Randomization Study

Shu-Yi Huang,Yu-Xiang Yang,Ya-Ru Zhang,Kevin Kuo,Hong-Qi Li,Xue-Ning Shen,Shi-Dong Chen,Ke-Liang Chen,Qiang Dong,Lan Tan,Jin-Tai Yu

DOI: https://doi.org/10.21203/rs.3.rs-467119/v2

2021-07-19

Abstract:Abstract Background Metabolomics is a promising approach that can be used to understand pathophysiological pathways of Alzheimer disease (AD). However, the relationships between metabolism and AD are poorly understood. The aim of this study is to investigate the causal association between circulating metabolites and risk of AD by combining metabolomics with genomics through two-sample Mendelian randomization (MR) approach. Methods Genetic associations with 123 circulating metabolic traits were utilized as exposures. A large summary statistics data from International Genomics of Alzheimer’s Project was used in primary analysis, including 21,982 AD cases and 41,944 controls. Validation was further performed using family history of AD data from UK Biobank (27,696 cases of maternal AD, 14,338 cases of paternal AD and 272,244 controls). We utilized the inverse-variance weighted method as primary analysis and four additional MR methods (MR-Egger, weighted median, weighted mode, and MR pleiotropy residual sum and outlier) for sensitivity analyses. Results We found one-fold increased risk of developing AD per standard deviation increase in the levels of circulating ApoB (odd ratio (OR)=3.18; 95% confidence interval (CI): 1.52–6.66, P=0.0022) and glycoprotein acetyls (OR=1.21; 95% CI: 1.05–1.39, P=0.0093), serum total cholesterol (OR=2.73; 95% CI: 1.41-5.30, P=0.0030), and low-density lipoprotein (LDL) cholesterol (OR=2.34; 95% CI: 1.53-3.57, P=0.0001). Whereas glutamine (OR=0.81; 95% CI: 0.71-0.92, P=0.0011) were significantly associated with lower risk of AD. We also detected causal effects of several different composition of LDL fractions on increased AD risk, which has been verified in validation. However, we found no association between circulating high-density lipoprotein cholesterol and AD. Conclusions Our findings provided robust evidence supporting causal effects of circulating glycoprotein acetyls, ApoB, LDL cholesterol, and serum total cholesterol on higher risk of AD, whereas glutamine showed the protective effect. Further research is required to decipher the biological pathways underpinning associations.
Life Course Adiposity And Alzheimer'S Disease: A Mendelian Randomization Study

Xian Li,Yan Tian,Yu-Xiang Yang,Ya-Hui Ma,Xue-Ning Shen,Shi-Dong Chen,Prof Qiang Dong,Lan Tan,Jin-Tai Yu

DOI: https://doi.org/10.3233/JAD-210345

2021-01-01

Journal of Alzheimer s Disease

Abstract:Background: Several studies showed that life course adiposity was associated with Alzheimer's disease (AD). However, the underlying causality remains unclear. Objective: We aimed to examine the causal relationship between life course adiposity and AD using Mendelian randomization (MR) analysis.Methods: Instrumental variants were obtained from large genome-wide association studies (GWAS) for life course adiposity, including birth weight (BW), childhood body mass index (BMI), adult BMI, waist circumference (WC), waist-to-hip ratio (WHR), and body fat percentage (BFP). A meta-analysis of GWAS for AD including 71,880 cases and 383,378 controls was used in this study. MR analyses were performed using inverse variance weighted (IVW), weighted median, and MR-Egger regression methods. We calculated odds ratios (ORs) per genetically predicted standard deviation (1-SD) unit increase in each trait for AD.Results: Genetically predicted 1-SD increase in adult BMI was significantly associated with higher risk of AD (IVW: OR = 1.03, 95% confidence interval [CI] = 1.01-1.05, p = 2.7 x 10(-3)) after Bonferroni correction. The weighted median method indicated a significant association between BW and AD (OR = 0.94, 95%CI = 0.90-0.98, p = 1.8 x 10(-3)). We also found suggestive associations of AD with WC (IVW: OR = 1.03, 95%CI = 1.00-1.07, p = 0.048) and WHR(weighted median: OR= 1.04, 95%CI = 1.00-1.07, p = 0.029). No association was detected of AD with childhood BMI and BFP.Conclusion: Our study demonstrated that lower BW and higher adult BMI had causal effects on increased AD risk.
The role of lipid species in Alzheimer's disease onset: A comprehensive Mendelian randomization analysis

Wen Wang,HongLian Xia

DOI: https://doi.org/10.1016/j.brainres.2024.149238

2024-09-13

Abstract:Background: Alzheimer's disease (AD) remains a significant global health challenge, with its etiology intricately linked to a variety of genetic and environmental factors. Among these, lipid metabolism has been hypothesized to play a crucial role, though the causal pathways remain inadequately elucidated. This study aims to employ Mendelian Randomization (MR) to unravel the potential causal relationships between a comprehensive array of lipid species and the risk of developing AD. Methods: Utilizing a two-sample MR framework, we analyzed data from genome-wide association studies (GWAS) encompassing 487,511 individuals of European descent. A total of 179 lipid species across 13 lipid categories were investigated for their causal association with AD. Genetic variants serving as instrumental variables (IVs) were carefully selected based on stringent criteria to ensure validity. The statistical analyses, including inverse variance weighting (IVW), weighted median-based estimation, and sensitivity analyses, were conducted using the R software environment. Results: Our findings reveal a significant causal relationship between ten specific lipid species and the risk of AD. Notably, certain lipids such as Sterol ester (27:1/15:0) and Phosphatidylcholine (16:0_22:4) exhibited a protective effect against AD, as evidenced by their inverse correlation with the disease's risk. Additionally, a reciprocal analysis suggested a negative causal impact of AD on the levels of certain Triacylglycerol species. The integrity of our results was reinforced by sensitivity analyses, including the MR Egger intercept test, indicating the absence of horizontal pleiotropy and confirming the reliability of our findings. Conclusions: This study substantiates the causal link between specific lipid species and Alzheimer's disease, highlighting the complex interplay between lipid metabolism and AD pathogenesis. The identified lipid biomarkers offer new insights into the disease's etiology and potential therapeutic targets. Furthermore, our rigorous methodological approach demonstrates the utility of MR in disentangling the causal relationships in complex diseases.
Genetic Insights into the Association and Causality Between Blood Metabolites and Alzheimer's Disease

Modi Zhai,Yu Zhang,Dongxue Yan,Yuzhen Wang,Wenzhong Li,Jie Sun

DOI: https://doi.org/10.3233/jad-230985

2024-03-13

Journal of Alzheimer s Disease

Abstract:Background: Alzheimer's disease (AD) is an increasing public health concern with the aging of the global population. Understanding the genetic correlation and potential causal relationships between blood metabolites and AD may provide important insights into the metabolic dysregulation underlying this neurodegenerative disorder. Objective: The aim of this study was to investigate the causal relationship between blood metabolites and AD using Mendelian randomization (MR) analysis. Methods: Association data were obtained from three large-scale genome-wide association studies of 486 blood metabolites (N = 7,824), AD (71,880 cases and 383,378 controls), early-onset AD (N = 303,760), and late-onset AD (N = 307,112). Causal associations between blood metabolites and AD were assessed using inverse variance weighting (IVW), MR-Egger, and weighted median methods. Bidirectional two-sample MR analysis was used to identify causal blood metabolites. MR-PRESSO, MR-Egger, and Cochran-Q were used to quantify instrumental variable heterogeneity and horizontal pleiotropy. Results: Using MR and sensitivity analysis, we identified 40 blood metabolites with potential causal associations with AD. After applying false discovery rate (FDR) correction, two metabolites, gamma-glutamylphenylalanine (OR = 1.15, 95% CI: 1.06–1.24, p = 3.88×10–4, q = 0.09) and X-11317 (OR = 1.16, 95% CI: 1.08–1.26, p = 1.14×10–4, q = 0.05), retained significant associations with AD. Reverse MR analysis indicated no significant causal effect of AD on blood metabolites. No significant instrumental variable heterogeneity or horizontal pleiotropy was found. Conclusions: This two-sample MR study provides compelling evidence for a potential causal relationship between blood metabolic dysregulation and susceptibility to AD. Further investigation of the biological relevance of the identified metabolites to AD and additional supporting evidence is warranted.

neurosciences
The impact of obesity and sexual behavior on prostate cancer risk is mediated by testosterone levels: a mendelian randomization study and mediation analysis

Huajie Di,Yi Wen,Junyan Wang,Jiayu Wang,Yeqing Wang,Yuan Li,Fanghao Sun

DOI: https://doi.org/10.1016/j.prnil.2024.03.003

Abstract:Background: The relationship between obesity, sexual behavior, and prostate cancer (PCa) has been widely debated, contributing to a lack of understanding of its potential mechanisms and hindering the development of effective prevention measures. Purpose: The aim of this study was to examine the causal effect of body mass index (BMI), age at first sexual intercourse (AFS), and bioavailable testosterone levels on PCa while also quantifying the potential roles of mediators. Method: We conducted a Mendelian randomization (MR) study using summary statistics from genome-wide associations of BMI (152,893 European males), AFS (182,791 European males), bioavailable testosterone (184,205 European males), and PCa (79,148 cases, 61,106 controls, European ancestry). Inverse-variance weighted method, weighted median method, MR-Egger regression, Least Absolute Shrinkage and Selection Operator (LASSO), and outlier test were used for MR analyses. Reverse MR and mediation analysis were performed. Data analyses were conducted from December 2022 to July 2023. Results: The results showed that genetic liability to BMI was protective of PCa (OR, 0.82; 95% CI: 0.74-0.91; P = 3.29 × 10-4). Genetic liability to later AFS (OR, 1.28; 95% CI: 1.08-1.53; P = 5.64 × 10-3) and higher bioavailable testosterone levels (OR = 1.11, 95% CI: 1.01-1.24, P = 0.04) were associated with an increased risk of PCa. All of these potential causal effects could only be forwarded and were not affected by prostate specific antigen (PSA) screening. After controlling for bioavailable testosterone levels, the causal impact of BMI and AFS on PCa was no longer significant. The mediation analysis suggested that the causal influence of AFS/BMI on PCa relied on bioavailable testosterone levels. Conclusion: In conclusion, the difference between the univariable and multivariable MR results suggested that the causal influence of BMI and AFS on PCa relied on bioavailable testosterone levels. Further work is needed to identify other risk factors and to elucidate the specific mechanisms that underlie this causal pathway.
Revealing a Novel Landscape of the Association Between Blood Lipid Levels and Alzheimer's Disease: A Meta-Analysis of a Case-Control Study

Qianyun Tang,Fengling Wang,Jingjing Yang,Hua Peng,Yu Li,Bin Li,Shuhong Wang

DOI: https://doi.org/10.3389/fnagi.2019.00370

IF: 4.8

2020-02-05

Frontiers in Aging Neuroscience

Abstract:Objectives: Blood lipid profiles have been ambiguously reported as biomarkers of AD in recent years. This study was conducted to evaluate the correlation between blood lipid levels and AD in later-life and to explore the effectiveness and reliability of blood lipid profiles as biomarkers of AD.Methods: Database searching was conducted using PubMed, the Cochrane Library, EMBASE, and Medline. This study was designed following the Meta-analysis of Observational Studies in Epidemiology (MOOSE) criteria. Review Manager 5.3 (RevMan 5.3) software was adopted to perform meta-analysis evaluating the standard mean difference (SMD) with its 95% confidence intervals (CI).Results: A total of 5,286 participants were enrolled from 27 case–control studies in this meta-analysis. The pooled results demonstrated that total cholesterol (TC) level was significantly associated with AD in late-life (SMD = 0.17, 95% CI: [0.01, 0.32], P = 0.03), especially in the subgroup under 70 years old (SMD: 0.45, 95% CI: [0.11, 0.79], P = 0.01) and the subgroup of Western population (SMD: 0.29, 95% CI: [0.04, 0.53], P = 0.02). In the subgroup under 70 years old, the high-density lipoprotein cholesterol (HDL-C) level (SMD = −0.50, 95% CI: [−0.76, −0.25], P = 0.0001) and the low-density lipoprotein cholesterol (LDL-C) level (SMD = 0.59, 95% CI: [0.02, 1.16], P = 0.04) in the AD group were significantly lower and higher than in the control group, respectively. In the subgroup with a sample size larger than 100 subjects, the LDL-C level was significantly higher in AD patients than in the control elderly group (SMD = 0.31, 95% CI: [0.05, 0.56], P = 0.02). There was no significant association between triglyceride (TG) levels and AD in later-life (SMD = −0.00, 95% CI: [−0.12, 0.12], P = 1.00).Conclusion: TC can be a new predictive biomarker of AD or cognitive decline in later-life. Increased TC levels are found to be associated with an elevated risk of AD. Decreased HDL-C levels and increased LDL-C levels may relate to an elevated risk of AD in subjects aged 60–70. Further comprehensive researches will be necessary in the future.

neurosciences,geriatrics & gerontology,gerontology
Causal Relationships Between Gut Metabolites and Alzheimer's Disease: a Bidirectional Mendelian Randomization Study.

Zhenhuang Zhuang,Meng Gao,Ruotong Yang,Zhonghua Liu,Weihua Cao,Tao Huang

DOI: https://doi.org/10.1016/j.neurobiolaging.2020.10.022

IF: 5.133

2021-01-01

Neurobiology of Aging

Abstract:Observational studies have shown that gut microbiota-dependent metabolites are associated with the risk of Alzheimer's disease (AD). However, whether such association reflects a causality remains unclear. We conducted a bidirectional Mendelian randomization analysis to examine the causal relationships between gut microbiota-dependent metabolites trimethylamine N-oxide (TMAO) or its predecessors and AD. We observed that genetically predicted TMAO (odds ratio: 0.99, 95% confidence interval: 0.89 to 1.09 per 10 units, p = 0.775) or its predecessors including betaine (1.06, 1.00 to 1.12 per 10 units, p = 0.056), carnitine (1.05, 0.98 to 1.12 per 10 units, p = 0.178), and choline (1.01, 0.92 to 1.10 per 10 units, p = 0.905) were not associated with the risk of AD. Our Mendelian randomization estimates from AD to metabolites showed that genetically predicted higher risk of AD was also not causally associated with TMAO, betaine, carnitine, and choline levels. Our findings support that gut microbiota-dependent metabolites TMAO or its predecessors do not play causal roles in the development of AD. (C) 2020 Elsevier Inc. All rights reserved.
Investigating the causal association between branched-chain amino acids and Alzheimer's disease: A bidirectional Mendelian randomized study

Xiao-hang Qian,Xiao-li Liu,Bin Zhang,Yuan Lin,Jian-hua Xu,Gang-yu Ding,Hui-dong Tang

DOI: https://doi.org/10.3389/fnut.2023.1103303

IF: 5

2023-04-01

Frontiers in Nutrition

Abstract:Background: There are many metabolic pathway abnormalities in Alzheimer's disease (AD). Several studies have linked branched-chain amino acids (BCAAs) metabolism disorders with AD, but have not obtained consistent results. The purpose of this study is to explore the causal association between the BCAAs concentration and the risk of AD. Methods: A bidirectional Mendelian randomized (MR) was applied to explore the causal effect between BCAAs level and the risk of AD. Genetic instrumental variables from the genome-wide association study (GWAS) of serum BCAAs levels [total BCAAs (115,047 participants), valine (115,048 participants), leucine (115,074 participants), isoleucine (115,075 participants)] from UK biobank and AD (21,982 AD cases and 41,944 controls) from the International Genomics of Alzheimer's Project) were applied to explore the causal effect through the inverse-variance weighted (IVW) method, MR Egger and Weighted median, accompanied by multiple pluripotency and heterogeneity tests. Results: The forward MR analysis showed that there were not casual effect of total BCAAs (OR: 1.067, 95% CI: 0.838-1.358; p = 0.838), valine (OR: 1.106, 95% CI: 0.917-1.333; p = 0.292), leucine (OR: 1.096, 95% CI: 0.861-1.396; p = 0.659), isoleucine (OR: 1.457, 95% CI: 1.024-2.742; p =0.037) level on the risk of AD. The reverse analysis showed that AD was related with reduced levels of total BCAAs (OR: 0.979, 95% CI: 0.989-0.990; p < 0.001), valine (OR: 0.977, 95% CI: 0.963-0.991; p = 0.001), leucine (OR: 0.983, 95% CI: 0.973-0.994; p = 0.002), isoleucine (OR: 0.982, 95% CI: 0.971-0.992; p = 0.001). Conclusion: We provide robust evidence that AD was associated with a decreased level of BCAAs, which can serve as a marker for early diagnosis of AD.

nutrition & dietetics
International blood import/export: recommendations for blood services and software developers

P. Ashford,M. Fearon,R. Bedford

DOI: https://doi.org/10.1111/j.1423-0410.2010.01421.x

2011-04-01

Vox Sanguinis

Abstract:In March 2009, the International Blood Emergency Planning Action Group (IBEPAG) and ICCBBA performed a survey on blood import ⁄ export and labelling [1]. As a follow-up activity, sample blood group labels from fifteen blood services were distributed to ABO ⁄ EBA members to assess the ability of blood services to import blood from other countries, based on label compatibility. Sixteen blood services from fourteen countries participated in this survey. The results show that in some areas compatibility between labels is good, particularly among the Scandinavian blood services who can readily exchange units. However, in spite of the implementation of a ‘universal’ labelling system, there are still significant barriers to reading labels exchanged between countries. There are three main reasons for this: (1) Software limitations imposed by blood establishment computer system (BECS). Many of these systems are configured specifically for local ⁄ national usage and do not permit import of validly labelled ISBT 128 compliant units (see Table 1). (2) Implementation limitations such as the use of national codes, which cannot be interpreted internationally, or non-standard implementation of ISBT 128 (see Table 2). (3) Limitations imposed by regulatory requirements. Similar effect to (1) above but in this case, the software system is capable of processing received units, but configuration parameters set to meet regulatory or accreditation requirements prevent import. An example may be regulatory control over the permitted product codes preventing import of units with valid, but not nationally licensed, products. The goal of ISBT 128 is to enable globally unique identification of donations and to provide standard reference tables, product description terminology and data structures to support the movement of blood components between blood services without the need for relabelling [2]. The system has proven highly effective in facilitating import ⁄ export of blood between blood services within a country [3]. However, this study has shown that a number of barriers to import ⁄ export at an international level remain. In the event of a major emergency severely disrupting national blood supply, import of blood may become an urgent necessity. Ensuring mechanisms exist to safely manage such imports should be a part of blood service emergency plans. This exercise has demonstrated situations where the import of blood was prevented despite labelling being in
A Phenome-wide Association and Mendelian Randomization Study for Alzheimer's Disease: A Prospective Cohort Study of 502,493 Participants from the UK Biobank.

Shi-Dong Chen,Wei Zhang,Yu-Zhu Li,Liu Yang,Yu-Yuan Huang,Yue-Ting Deng,Bang-Sheng Wu,John Suckling,Edmund T. Rolls,Feng,Wei Cheng,Qiang Dong,Jin-Tai Yu

DOI: https://doi.org/10.1016/j.biopsych.2022.08.002

IF: 12.81

2023-01-01

Biological Psychiatry

Abstract:BACKGROUND:Considerable uncertainty remains regarding associations of multiple risk factors with Alzheimer's disease (AD). We aimed to systematically screen and validate a wide range of potential risk factors for AD.METHODS:Among 502,493 participants from the UK Biobank, baseline data were extracted for 4171 factors spanning 10 different categories. Phenome-wide association analyses and time-to-event analyses were conducted to identify factors associated with both polygenic risk scores for AD and AD diagnosis at follow-up. We performed two-sample Mendelian randomization analysis to further assess their potential causal relationships with AD and imaging association analysis to discover underlying mechanisms.RESULTS:We identified 39 factors significantly associated with both AD polygenic risk scores and risk of incident AD, where higher levels of education, body size, basal metabolic rate, fat-free mass, computer use, and cognitive functions were associated with a decreased risk of developing AD, and selective food intake and more outdoor exposures were associated with an increased risk of developing AD. The identified factors were also associated with AD-related brain structures, including the hippocampus, entorhinal cortex, and inferior/middle temporal cortex, and 21 of these factors were further supported by Mendelian randomization evidence.CONCLUSIONS:To our knowledge, this is the first study to comprehensively and rigorously assess the effects of wide-ranging risk factors on AD. Strong evidence was found for fat-free body mass, basal metabolic rate, computer use, selective food intake, and outdoor exposures as new risk factors for AD. Integration of genetic, clinical, and neuroimaging information may help prioritize risk factors and prevention targets for AD.
Association between dietary fat intake and the risk of Alzheimer's disease: Mendelian randomisation study

Yunqing Zhu,Yongbing Lan,Jun Lv,Dianjianyi Sun,Liming Li,Dai Zhang,Canqing Yu,Weihua Yue

DOI: https://doi.org/10.1192/bjp.2024.163

2024-10-13

The British Journal of Psychiatry

Abstract:Background Observational studies have shown a controversial relationship between dietary fat intake and Alzheimer's disease, and the causal effects are unclear. Aims To assess the causal effects of total fat, saturated fat and polyunsaturated fat (PUF) intakes on the risk of Alzheimer's disease. Method A two-sample Mendelian randomisation analysis was performed using genome-wide association study summary statistics on different types of fat intake from UK Biobank (n = 51 413) and on late-onset Alzheimer's disease (LOAD; 4282 cases, n = 307 112) and all forms of Alzheimer's disease (6281 cases, n = 309 154) from the FinnGen consortium. In addition, a multivariable Mendelian randomisation (MVMR) analysis was conducted to estimate the effects independent of carbohydrate and protein intakes. Results Genetically predicted per standard deviation increase in the total fat and saturated fat intakes were associated with 44 and 38% higher risks of LOAD (total fat: odds ratio = 1.44, 95% CI 1.03–2.02; saturated fat: odds ratio = 1.38, 95% CI 1.002–1.90; P = 0.049). The associations remained significant in the MVMR analysis (total fat: odds ratio = 3.31, 95% CI 1.74–6.29; saturated fat: odds ratio = 2.04, 95% CI 1.16–3.59). Total fat and saturated fat intakes were associated with a higher risk of all forms of Alzheimer's disease in the MVMR analysis (total fat: odds ratio = 2.09, 95% CI 1.22–3.57; saturated fat: odds ratio = 1.60, 95% CI 1.01–2.52). The PUF intake was not associated with LOAD or all forms of Alzheimer's disease. Conclusions This study indicated that total dietary fat intake, especially saturated fat, contributed to the risk of Alzheimer's disease, and the effects were independent of other nutrients. These findings informed prevention strategies and management for Alzheimer's disease directly towards reducing dietary saturated fat intake.

psychiatry
Low Testosterone Level and Risk of Alzheimer’s Disease in the Elderly Men: a Systematic Review and Meta-Analysis

Wenshan Lv,Na Du,Ying Liu,Xinyi Fan,Yunyang Wang,Xiujuan Jia,Xu Hou,Bin Wang

DOI: https://doi.org/10.1007/s12035-015-9315-y

IF: 5.682

2015-01-01

Molecular Neurobiology

Abstract:Sex steroids can positively affect the brain function, and low levels of sex steroids may be associated with worse cognitive function in the elderly men. However, previous studies reported contrary findings on the relationship between testosterone level and risk of Alzheimer’s disease in the elderly men. The objective of this study was to comprehensively assess the relationship between low testosterone level and Alzheimer’s disease risk in the elderly men using a meta-analysis. Only prospective cohort studies assessing the influence of low testosterone level on Alzheimer’s disease risk in elderly men were considered eligible. Relative risks (RRs) with 95 % confidence intervals (95 % CI) were pooled to assess the risk of Alzheimer’s disease in elderly men with low testosterone level. Seven prospective cohort studies with a total of 5251 elderly men and 240 cases of Alzheimer’s disease were included into the meta-analysis. There was moderate degree of heterogeneity among those included studies ( I 2 = 47.2 %). Meta-analysis using random effect model showed that low plasma testosterone level was significantly associated with an increased risk of Alzheimer’s disease in elderly men (random RR = 1.48, 95 % CI 1.12–1.96, P = 0.006). Sensitivity analysis by omitting one study by turns showed that there was no obvious change in the pooled risk estimates, and all pooled RRs were statistically significant. This meta-analysis supports that low plasma testosterone level is significantly associated with increased risk of Alzheimer’s disease in the elderly men. Low testosterone level is a risk factor of worse cognitive function in the elderly men.
Causal effect of blood osteocalcin on the risk of Alzheimer's disease and the mediating role of energy metabolism

Xingzhi Guo,Yu-ying Yang,Rong Zhou,Ge Tian,Chang Shan,Jian-min Liu,Rui Li

DOI: https://doi.org/10.1038/s41398-024-02924-w

2024-05-21

Translational Psychiatry

Abstract:Growing evidence suggests an association between osteocalcin (OCN), a peptide derived from bone and involved in regulating glucose and lipid metabolism, and the risk of Alzheimer's disease (AD). However, the causality of these associations and the underlying mechanisms remain uncertain. We utilized a Mendelian randomization (MR) approach to investigate the causal effects of blood OCN levels on AD and to assess the potential involvement of glucose and lipid metabolism. Independent instrumental variables strongly associated ( P < 5E-08) with blood OCN levels were obtained from three independent genome-wide association studies (GWAS) on the human blood proteome ( N = 3301 to 35,892). Two distinct summary statistics datasets on AD from the International Genomics of Alzheimer's Project (IGAP, N = 63,926) and a recent study including familial-proxy AD patients (FPAD, N = 472,868) were used. Summary-level data for fasting glucose (FG), 2h-glucose post-challenge, fasting insulin, HbA1c, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, total cholesterol (TC), and triglycerides were incorporated to evaluate the potential role of glucose and lipid metabolism in mediating the impact of OCN on AD risk. Our findings consistently demonstrate a significantly negative correlation between genetically determined blood OCN levels and the risk of AD (IGAP: odds ratio [OR, 95%CI] = 0.83[0.72–0.96], P = 0.013; FPAD: OR = 0.81 [0.70–0.93], P = 0.002). Similar estimates with the same trend direction were obtained using other statistical approaches. Furthermore, employing multivariable MR analysis, we found that the causal relationship between OCN levels and AD was disappeared after adjustment of FG and TC (IGAP: OR = 0.97[0.80–1.17], P = 0.753; FPAD: OR = 0.98 [0.84–1.15], P = 0.831). There were no apparent instances of horizontal pleiotropy, and leave-one-out analysis showed good stability of the estimates. Our study provides evidence supporting a protective effect of blood OCN levels on AD, which is primarily mediated through regulating FG and TC levels. Further studies are warranted to elucidate the underlying physio-pathological mechanisms.

psychiatry
Association between plasma brain-derived neurotrophic factor level and Alzheimer’s disease: a Mendelian randomization study

Jiaxing You,Yinan Wang,Xinyue Chang,Yi Liu,Yu He,Xiya Zhou,Jinyan Zou,Meng Xiao,Mengyao Shi,Daoxia Guo,Ouxi Shen,Zhengbao Zhu

DOI: https://doi.org/10.2174/0115672026281995231227070637

2024-01-25

Current Neurovascular Research

Abstract:Background: High brain-derived neurotrophic factor (BDNF) concentrations have been found to be associated with a decreased risk of Alzheimer’s disease (AD) in observational studies, but the causality for this association remains unclear. Therefore, we aimed to examine the association between genetically determined plasma BDNF levels and AD using a two-sample Mendelian randomization (MR) method. Methods: Twenty single-nucleotide polymorphisms associated with plasma BDNF concentrations were identified as genetic instruments based on a genome-wide association study with 3301 European individuals. Summary-level data on AD were obtained from the International Genomics of Alzheimer’s Project, involving 21,982 AD cases and 41,944 controls of European ancestry. To evaluate the relationship between plasma BDNF concentrations and AD, we employed the inverse-variance weighted method along with a series of sensitivity analyses. Results: The inverse-variance weighted MR analysis showed that genetically determined BDNF concentrations were associated with a decreased risk of AD (odds ratio per SD increase, 0.91; 95% confidence interval, 0.86-0.96; p =0.001). The association between plasma BDNF concentrations and AD was further confirmed through sensitivity analyses using different MR methods, and MR-Egger regression suggested no directional pleiotropy for this association. Conclusion: Genetically determined BDNF levels were associated with a decreased risk of AD, suggesting that BDNF was implicated in the development of AD and might be a promising target for the prevention of AD.

neurosciences,clinical neurology
5E-3 Simulation of Thin Piezoelectric Structures Using Anisotropic Hierarchic Finite Elements

A. Hauck,M. Kaltenbacher,R. Lerch

DOI: https://doi.org/10.1109/ULTSYM.2006.127

2006-10-01

Abstract:Thin piezoelectric structures are important parts of active-noise cancellation devices and smart structures. For these kind of applications it is crucial to get an accurate prediction of the frequency characteristics using the finite element method (FEM). Instead of using plate elements, we concentrate on a pure three dimensional approach using hierarchic ansatz spaces for hexahedral elements with the option of anisotropic choice of approximation order. The use of higher order Legendre polynomials reduces the susceptibility to locking, while the anisotropic choice of approximation order allows to minimize the number of degrees of freedom for the mechanical displacement and electric potential. The applicability of the method is proven by a pure mechanical example of a plate under uniform pressure, as well as for a piezoelectric bimorph beam
Genetically determined dietary habits and risk of Alzheimer's disease: a Mendelian randomization study

Fei Teng,Jiahui Sun,Zheyu Chen,Hao Li

DOI: https://doi.org/10.3389/fnut.2024.1415555

2024-06-03

Abstract:Background: Emerging evidence have suggested that dietary habits have potential implication on the development of Alzheimer's disease (AD). However, elucidating the causal relationship between specific dietary factors and AD risk remains a challenge. Therefore, our study endeavors to investigate the causal association between dietary habits and the risk of AD. Materials and methods: We analyzed data on 231 dietary habits sourced from the UK Biobank and MRC-IEU, and AD data obtained from the FinnGen database. Employing a framework based on the classic two-sample Mendelian randomization (MR) study, we utilized the inverse-variance weighted (IVW) method as the primary analysis. Additionally, we conducted Steiger filtering and other methods to mitigate horizontal pleiotropy. The robustness of our overall findings was confirmed through multiple sensitivity analysis methods, and forward MR and reverse MR to address potential reverse causality bias. Results: Our study evaluated the causal effect between 231 dietary habits involving over 500,000 participants of European ancestry, and 10,520 AD cases. Only oily fish intake demonstrated a significant protective causal relationship with AD following FDR correction (raw p-value = 1.28e-4, FDR p-value = 0.011, OR = 0.60, 95%CI: 0.47-0.78). Additionally, six dietary habits potentially influenced AD risk, with protective causal effects observed for average monthly intake of other alcoholic drinks (raw p-value = 0.024, FDR p-value = 0.574, OR = 0.57, 95%CI: 0.35-0.93) and tea intake (raw p-value = 0.047, FDR p-value = 0.581, OR = 0.78, 95%CI: 0.603-1.00). Conversely, detrimental causal effects were observed for the average weekly champagne plus white wine intake (raw p-value = 0.006, FDR p-value = 0.243, OR = 2.96, 95%CI: 1.37-6.38), Danish pastry intake (raw p-value = 0.036, FDR p-value = 0.574, OR = 13.33, 95%CI: 1.19-149.69), and doughnut intake (raw p-value = 0.039, FDR p-value = 0.574, OR = 7.41, 95%CI: 1.11-49.57). Moreover, the protective effect of goat's cheese intake phenotype exhibited statistical significance only in the IVW method (raw p-value<0.05). Conclusion: Our results provide genetic support for a protective causal effect of oily fish intake on AD risk. Additionally, average monthly intake of other alcoholic drinks and tea consumption were also related with a lower risk of AD. Conversely, average weekly champagne plus white wine intake, Danish pastry intake, and doughnut intake were causally associated with increased risk of AD.

Human coagulation factor IX: direct depletion and recovery from plasma, using immobilised monoclonal antibody.

Evolutionary approach to the analysis of structure and function of gangliosides

Characterization of Bacterial Biofilms for Wastewater Treatment

Investigating Causal Relations Between Circulating Metabolites and Alzheimer's Disease: A Mendelian Randomization Study

The Potential Effect of Aberrant Testosterone Levels on Common Diseases: A Mendelian Randomization Study

Investigating Causal Relations Between Circulating Metabolites and Alzheimer’s Diseases: A Mendelian Randomization Study

Life Course Adiposity And Alzheimer'S Disease: A Mendelian Randomization Study

The role of lipid species in Alzheimer's disease onset: A comprehensive Mendelian randomization analysis

Genetic Insights into the Association and Causality Between Blood Metabolites and Alzheimer's Disease

The impact of obesity and sexual behavior on prostate cancer risk is mediated by testosterone levels: a mendelian randomization study and mediation analysis

Revealing a Novel Landscape of the Association Between Blood Lipid Levels and Alzheimer's Disease: A Meta-Analysis of a Case-Control Study

Causal Relationships Between Gut Metabolites and Alzheimer's Disease: a Bidirectional Mendelian Randomization Study.

Investigating the causal association between branched-chain amino acids and Alzheimer's disease: A bidirectional Mendelian randomized study

International blood import/export: recommendations for blood services and software developers

A Phenome-wide Association and Mendelian Randomization Study for Alzheimer's Disease: A Prospective Cohort Study of 502,493 Participants from the UK Biobank.

Association between dietary fat intake and the risk of Alzheimer's disease: Mendelian randomisation study

Low Testosterone Level and Risk of Alzheimer’s Disease in the Elderly Men: a Systematic Review and Meta-Analysis

Causal effect of blood osteocalcin on the risk of Alzheimer's disease and the mediating role of energy metabolism

Association between plasma brain-derived neurotrophic factor level and Alzheimer’s disease: a Mendelian randomization study

5E-3 Simulation of Thin Piezoelectric Structures Using Anisotropic Hierarchic Finite Elements

Genetically determined dietary habits and risk of Alzheimer's disease: a Mendelian randomization study